Denali Therapeutics Inc. (NASDAQ:DNLI) Given Average Recommendation of Buy by Analysts

Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) has been given an average rating of “Buy” by the eleven brokerages that are covering the company, MarketBeat.com reports. Eleven analysts have rated the stock with a buy rating. The average 1 year price target among brokerages that have issued a report on the stock in the […]

Related Keywords

China ,Vickil Sato , ,China Universal Asset Management Co ,Denali Therapeutics Inc ,Cantor Fitzgerald ,Citigroup ,Assetmark Inc ,Nasdaq ,Jpmorgan Chase Co ,Financial Services Group Inc ,Denali Therapeutics ,Get Free Report ,Therapeutics Stock Down ,Director Vicki ,Services Group ,Investment Management ,Universal Asset Management ,Get Free ,Therapeutics Inc ,Denali Therapeutics Daily ,Nasdaq Dnli ,Dnli ,Medical ,Ratings ,Consensus ,